143 related articles for article (PubMed ID: 12107643)
21. Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.
Herrera MC; Palomero MF; Macias RI; Serrano MA; Marin JJ
Anticancer Res; 1998; 18(5A):3555-63. PubMed ID: 9858939
[TBL] [Abstract][Full Text] [Related]
22. First bivalent palladium and platinum cyanoximates: synthesis, characterization, and biological activity.
Eddings D; Barnes C; Gerasimchuk N; Durham P; Domasevich K
Inorg Chem; 2004 Jun; 43(13):3894-909. PubMed ID: 15206870
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
Miernicka M; Szulawska A; Czyz M; Lorenz IP; Mayer P; Karwowski B; Budzisz E
J Inorg Biochem; 2008 Feb; 102(2):157-65. PubMed ID: 17868889
[TBL] [Abstract][Full Text] [Related]
24. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
25. Pd(II) and Pt(II) complexes with aromatic diamines: study of their interaction with DNA.
Pérez-Cabré M; Cervantes G; Moreno V; Prieto MJ; Pérez JM; Font-Bardia M; Solans X
J Inorg Biochem; 2004 Mar; 98(3):510-21. PubMed ID: 14987853
[TBL] [Abstract][Full Text] [Related]
26. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
[TBL] [Abstract][Full Text] [Related]
27. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C
Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352
[TBL] [Abstract][Full Text] [Related]
28. Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
Kruszewski M; Bouzyk E; Oldak T; Samochocka K; Fuks L; Lewandowski W; Fokt I; Priebe W
Teratog Carcinog Mutagen; 2003; Suppl 1():1-11. PubMed ID: 12616592
[TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents.
Keter FK; Kanyanda S; Lyantagaye SS; Darkwa J; Rees DJ; Meyer M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):127-38. PubMed ID: 18350297
[TBL] [Abstract][Full Text] [Related]
30. 2-Benzoylpyridine-N(4)-tolyl thiosemicarbazones and their palladium(II) complexes: cytotoxicity against leukemia cells.
Ferraz KS; Ferandes L; Carrilho D; Pinto MC; Leite Mde F; Souza-Fagundes EM; Speziali NL; Mendes IC; Beraldo H
Bioorg Med Chem; 2009 Oct; 17(20):7138-44. PubMed ID: 19773176
[TBL] [Abstract][Full Text] [Related]
31. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats.
Ali BH; Al-Moundhri M; Tageldin M; Al Husseini IS; Mansour MA; Nemmar A; Tanira MO
Food Chem Toxicol; 2008 Nov; 46(11):3355-9. PubMed ID: 18790000
[TBL] [Abstract][Full Text] [Related]
32. Binding studies of a novel antitumor palladium(II) complex to calf thymus DNA.
Mansouri-Torshizi H; Saeidifar M; Divsalar A; Saboury AA
Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):405-22. PubMed ID: 21780907
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats.
Atasoyu EM; Yildiz S; Bilgi O; Cermik H; Evrenkaya R; Aktas S; Gültepe M; Kandemir EG
Arch Toxicol; 2005 May; 79(5):289-93. PubMed ID: 15902426
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic activity and chemical reactivity of cis-platinum(II) and trans-palladium(II) complexes with diethyl (pyridinylmethyl)phosphates.
Kalinowska-Lis U; Szmigiero L; Studzian K; Ochocki J
Eur J Med Chem; 2009 Feb; 44(2):660-4. PubMed ID: 18586354
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, structural characterization, and antitumor activity of palladium(II) complexes containing a sugar unit.
Brudziñska I; Mikata Y; Obata M; Ohtsuki C; Yano S
Bioorg Med Chem Lett; 2004 May; 14(10):2533-6. PubMed ID: 15109645
[TBL] [Abstract][Full Text] [Related]
36. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cytotoxicity of new trans-palladium(II) complex in human cells in vitro.
Kontek R; Matławska-Wasowska K; Kalinowska-Lis U; Kontek B; Ochocki J
Acta Pol Pharm; 2011; 68(1):127-36. PubMed ID: 21485711
[TBL] [Abstract][Full Text] [Related]
38. Interaction studies between a 1,10-phenanthroline adduct of palladium(II) dithiocarbamate anti-tumor complex and calf thymus DNA. A synthesis spectral and in-vitro study.
Mansouri-Torshizi H; Saeidifar M; Divsalar A; Saboury AA
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Sep; 77(1):312-8. PubMed ID: 20558101
[TBL] [Abstract][Full Text] [Related]
39. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines.
Pluim D; van Waardenburg RC; Beijnen JH; Schellens JH
Cancer Chemother Pharmacol; 2004 Jul; 54(1):71-8. PubMed ID: 15034754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
